Henry Schein Inc (HSIC)vs111 Inc (YI)
HSIC
Henry Schein Inc
$74.25
+0.31%
HEALTHCARE · Cap: $8.71B
YI
111 Inc
$6.29
-1.02%
HEALTHCARE · Cap: $58.07M
Smart Verdict
WallStSmart Research — data-driven comparison
111 Inc generates 3% more annual revenue ($13.58B vs $13.18B). HSIC leads profitability with a 3.0% profit margin vs -0.5%. HSIC earns a higher WallStSmart Score of 56/100 (C).
HSIC
Buy56
out of 100
Grade: C
YI
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+12.5%
Fair Value
$93.39
Current Price
$74.25
$19.14 discount
Intrinsic value data unavailable for YI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
Expensive relative to growth rate
3.0% margin — thin
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -10.9% — below average capital efficiency
Revenue declined 16.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : HSIC
The strongest argument for HSIC centers on Price/Book.
Bull Case : YI
The strongest argument for YI centers on Debt/Equity, Altman Z-Score.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.
Bear Case : YI
The primary concerns for YI are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
HSIC profiles as a value stock while YI is a turnaround play — different risk/reward profiles.
HSIC carries more volatility with a beta of 0.85 — expect wider price swings.
HSIC is growing revenue faster at 7.7% — sustainability is the question.
HSIC generates stronger free cash flow (338M), providing more financial flexibility.
Bottom Line
HSIC scores higher overall (56/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →111 Inc
HEALTHCARE · MEDICAL DISTRIBUTION · China
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?